Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 7
2003 3
2004 10
2005 3
2006 5
2007 10
2008 11
2009 3
2010 13
2011 13
2012 12
2013 16
2014 25
2015 22
2016 24
2017 38
2018 36
2019 36
2020 41
2021 30
2022 23
2023 26
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

370 results

Results by year

Filters applied: . Clear all
Page 1
Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates.
Uraki R, Iida S, Halfmann PJ, Yamayoshi S, Hirata Y, Iwatsuki-Horimoto K, Kiso M, Ito M, Furusawa Y, Ueki H, Sakai-Tagawa Y, Kuroda M, Maemura T, Kim T, Mine S, Iwamoto N, Li R, Liu Y, Larson D, Fukushi S, Watanabe S, Maeda K, Wang Z, Ohmagari N, Theiler J, Fischer W, Korber B, Imai M, Suzuki T, Kawaoka Y. Uraki R, et al. Among authors: kuroda m. Nat Commun. 2023 Mar 23;14(1):1620. doi: 10.1038/s41467-023-37059-x. Nat Commun. 2023. PMID: 36959194 Free PMC article.
An Antiviral Role for TRIM14 in Ebola Virus Infection.
Kuroda M, Halfmann PJ, Thackray LB, Diamond MS, Feldmann H, Marzi A, Kawaoka Y. Kuroda M, et al. J Infect Dis. 2023 Nov 15;228(Suppl 7):S514-S521. doi: 10.1093/infdis/jiad325. J Infect Dis. 2023. PMID: 37562033
Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents.
Uraki R, Halfmann PJ, Iida S, Yamayoshi S, Furusawa Y, Kiso M, Ito M, Iwatsuki-Horimoto K, Mine S, Kuroda M, Maemura T, Sakai-Tagawa Y, Ueki H, Li R, Liu Y, Larson D, Fukushi S, Watanabe S, Maeda K, Pekosz A, Kandeil A, Webby RJ, Wang Z, Imai M, Suzuki T, Kawaoka Y. Uraki R, et al. Among authors: kuroda m. Nature. 2022 Dec;612(7940):540-545. doi: 10.1038/s41586-022-05482-7. Epub 2022 Nov 2. Nature. 2022. PMID: 36323336
Genomic analysis of SARS-CoV-2 in forensic autopsy cases of COVID-19.
Hirata Y, Katano H, Iida S, Mine S, Nagasawa S, Makino Y, Motomura A, Ozono S, Sato Y, Sekizuka T, Kuroda M, Yamaguchi R, Inokuchi G, Torimitsu S, Akitomi S, Yajima D, Saitoh H, Suzuki T, Iwase H. Hirata Y, et al. Among authors: kuroda m. J Med Virol. 2023 Aug;95(8):e28990. doi: 10.1002/jmv.28990. J Med Virol. 2023. PMID: 37537838
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2.
Uraki R, Kiso M, Iida S, Imai M, Takashita E, Kuroda M, Halfmann PJ, Loeber S, Maemura T, Yamayoshi S, Fujisaki S, Wang Z, Ito M, Ujie M, Iwatsuki-Horimoto K, Furusawa Y, Wright R, Chong Z, Ozono S, Yasuhara A, Ueki H, Sakai-Tagawa Y, Li R, Liu Y, Larson D, Koga M, Tsutsumi T, Adachi E, Saito M, Yamamoto S, Hagihara M, Mitamura K, Sato T, Hojo M, Hattori SI, Maeda K, Valdez R; IASO study team; Okuda M, Murakami J, Duong C, Godbole S, Douek DC, Maeda K, Watanabe S, Gordon A, Ohmagari N, Yotsuyanagi H, Diamond MS, Hasegawa H, Mitsuya H, Suzuki T, Kawaoka Y. Uraki R, et al. Among authors: kuroda m. Nature. 2022 Jul;607(7917):119-127. doi: 10.1038/s41586-022-04856-1. Epub 2022 May 16. Nature. 2022. PMID: 35576972 Free PMC article.
Transmission and re-infection of Omicron variant XBB.1.5 in hamsters.
Halfmann PJ, Uraki R, Kuroda M, Iwatsuki-Horimoto K, Yamayoshi S, Ito M, Kawaoka Y. Halfmann PJ, et al. Among authors: kuroda m. EBioMedicine. 2023 Jul;93:104677. doi: 10.1016/j.ebiom.2023.104677. Epub 2023 Jun 21. EBioMedicine. 2023. PMID: 37352827 Free PMC article.
Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariants.
Changrob S, Halfmann PJ, Liu H, Torres JL, McGrath JJC, Ozorowski G, Li L, Wilbanks GD, Kuroda M, Maemura T, Huang M, Zheng NY, Turner HL, Erickson SA, Fu Y, Yasuhara A, Singh G, Monahan B, Mauldin J, Srivastava K, Simon V, Krammer F, Sather DN, Ward AB, Wilson IA, Kawaoka Y, Wilson PC. Changrob S, et al. Among authors: kuroda m. J Clin Invest. 2023 Apr 17;133(8):e166844. doi: 10.1172/JCI166844. J Clin Invest. 2023. PMID: 36862518 Free PMC article.
Characterization of the SARS-CoV-2 B.1.621 (Mu) variant.
Halfmann PJ, Kuroda M, Armbrust T, Theiler J, Balaram A, Moreno GK, Accola MA, Iwatsuki-Horimoto K, Valdez R, Stoneman E, Braun K, Yamayoshi S, Somsen E, Baczenas JJ, Mitamura K, Hagihara M, Adachi E, Koga M, McLaughlin M, Rehrauer W, Imai M, Yamamoto S, Tsutsumi T, Saito M, Friedrich TC, O'Connor SL, O'Connor DH, Gordon A, Korber B, Kawaoka Y. Halfmann PJ, et al. Among authors: kuroda m. Sci Transl Med. 2022 Aug 10;14(657):eabm4908. doi: 10.1126/scitranslmed.abm4908. Epub 2022 Aug 10. Sci Transl Med. 2022. PMID: 35579540 Free PMC article.
HER2-mediated enhancement of Ebola virus entry.
Kuroda M, Halfmann P, Kawaoka Y. Kuroda M, et al. PLoS Pathog. 2020 Oct 14;16(10):e1008900. doi: 10.1371/journal.ppat.1008900. eCollection 2020 Oct. PLoS Pathog. 2020. PMID: 33052961 Free PMC article.
370 results